moneycontrol.com4 年
Coronavirus vaccine update: Serum Institute of India says will resume trials after DCGI nod
Serum Institute of India (SII) will resume clinical trials of AstraZeneca's COVID-19 vaccine candidate after getting the permission from the Drugs Controller General of India (DCGI), the Pune ...
Business Insider India4 年
Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI
Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country SII ...
Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene ...
HYDERABAD: Dr Reddy’s Laboratories’ wholly-owned subsidiary, Aurigene Oncology Limited, has received Drugs Controller General ...
Business Insider India4 年
DCGI gives nod to India's first indigenous mRNA vaccine for human trial
Gennova has completed all preliminary work and should be initiating the Phase I/II Human clinical trial soon since the approval from the DCGI office has been received. The Department of ...